Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests if lifestyle tips can cut chemical exposure

NCT ID NCT07465315

Knowledge-focused Sponsor: Universidad de Granada Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether a behavioral program—including informative guidelines and social network support—can help adults in Spain reduce their exposure to environmental chemical pollutants. 740 participants aged 30-60 will be randomly assigned to either the program or standard healthy lifestyle advice. The main goal is to see if the program leads to a decrease in pollutant levels over 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (informative guidelines and social network interaction)
What this could lead to
If successful, this could provide a simple, low-cost way for people to reduce their exposure to everyday chemical pollutants.
What could go wrong
This is an early-stage study with a relatively short follow-up of 3 months. The intervention may not produce lasting changes, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 740 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for the Screening phase: * Not planning to change residence within one year after recruitment * Spanish fluency * Living independently in the community * WhatsApp user * Age 30-60 years * Providing signed informed consent Exclusion Criteria for the Screening phase: * Unable to provide any of the required biological samples * Suffering any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses * Inability to understand the informed consent, questionnaires, or intervention * Already participating in another intervention trial at the time of recruitment * Pregnancy or lactation * Inability to communicate with the research team and/or to attend the follow-up visits Inclusion Criteria for the Intervention Phase: * Not planning to change residence within one year after recruitment * Spanish fluency * Living independently in the community * WhatsApp user * Age 30-60 years * Providing signed informed consent * Participant of the Screening phase Exclusion Criteria for the Intervention Phase: * Unable to provide any of the required biological samples * Suffering from any chronic condition that substantially hinders adherence to the trial protocol and/or affects pollutant analyses * Inability to understand the informed consent, questionnaires, or intervention * Already participating in another intervention trial at the time of recruitment * Pregnancy or lactation * Inability to communicate with the research team and/or attend follow-up visits

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Environmental exposure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Environmental exposure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Clínica de neurociencias Imbrain

    Melilla, Melilla, 52001, Spain

  • Hospital Comarcal Santa Ana

    Motril, Granada, 18600, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, 28041, Spain

  • Hospital Universitario Clínico San Cecilio

    Granada, Granada, 18007, Spain

  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Madrid, 28942, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.